SARS CoV 2 News and Research

RSS

Excess COVID-19-associated death estimates by World Health Organization

Researchers presented a comprehensive report on the estimated impact of the SARS-CoV-2 pandemic by estimating month-wise excess deaths for the years 2020 and 2021.

16 Dec 2022

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Less known to the general public, mucosal vaccination via the mucus membranes could provide robust protection against SARS-CoV-2 infections.

16 Dec 2022

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Researchers investigated whether coronavirus disease 2019 (COVID-19)-associated chemosensory alterations were predictive of serological responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among United States (US) residents.

16 Dec 2022

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Researchers investigated the cellular tropism, replication competence, persistence and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, and associated histopathological changes in infected tissues.

16 Dec 2022

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against death, hospitalizations and emergency department (ED) visits for any cause, including COVID, research-scientists from Regenstrief Institute, Indiana University School of Medicine and Vanderbilt University Medical Center report that people of all age groups benefited significantly more from vaccination than natural immunity acquired from a previous COVID infection.

16 Dec 2022

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers developed a one-dose subunit vaccine for the induction of durable, potent, and broad immunity against SARS-CoV-2.

16 Dec 2022

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Researchers used serological measurements from a longitudinal cohort to evaluate the use of binding antibodies against the SARS-CoV-2 spike protein receptor binding domain as correlates of protection against the immune evasive Omicron subvariants BA.1 and BA.2.

16 Dec 2022

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Researchers investigated the efficacy of ritonavir and nirmatrelvir combination treatment in reducing the risk of COVID-19 severity outcomes such as hospital admissions and deaths when administered during the initial period of SARS-CoV-2 infections.

16 Dec 2022

Study reports that delaying surgery post-COVID-19 reduces the risk of postoperative cardiovascular issues

Researchers assessed the temporal relationship between COVID-19 diagnosis and surgery time with the risk of occurrence of cardiovascular morbidity events within 30 days of surgery.

16 Dec 2022

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

Researchers demonstrated the exceptional immune evasion properties of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, BQ and XBB.

16 Dec 2022

The impact of the US vaccination program on reducing infections, hospitalizations, and deaths

A recent study reported that in the two years following the initiation of the US COVID-19 vaccination campaign, over 18 million hospitalizations and three million deaths have been prevented, and close to $1.15 trillion have been saved in medical costs.

16 Dec 2022

Data mining approaches for the detection of signals associated with pediatric post-acute sequelae of COVID-19

Researchers described tree-based scan statistics for pediatric long COVID-19.

16 Dec 2022

mRNA vaccine methodologies: Production, value and spectrometer use

To be decided by the editor

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 16 Dec 2022

New system based on AI enables mass detection of Covid cases with a sensitivity of 97%

Washing your hands with hydroalcoholic gel, smelling it and using a QR code to answer a short questionnaire.

15 Dec 2022

Unexpected findings on the risk of SARS-CoV-2 infection

A new paper in Biology Methods & Protocols, published by Oxford University Press, investigates risk factors and protections against contracting COVID-19, and also for suffering from severe COVID.

15 Dec 2022

Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

Scientists identify an immunogenic epitope at the furin cleavage site of the SARS-CoV-2 spike protein.

15 Dec 2022

The UK's growing burden of long-COVID

Long COVID symptoms are more common in females and White identifying individuals between the ages of 35-49 years, as well as the disabled.

15 Dec 2022

Novel machine learning method detects animal coronaviruses that might infect humans

Researchers used machine learning (ML) tools to discover animal coronaviruses (CoVs), both alpha and beta CoVs, previously unknown to infect humans.

15 Dec 2022

New immunosensor could be a fast, inexpensive, and convenient tool to detect COVID-19

A new immunosensor based on Quenchbody technology shows great potential as a fast, inexpensive, and convenient tool to detect SARS-CoV-2.

15 Dec 2022

Exploring dynamics of emergence and spread of SARS-CoV-2 variants of concern

Researchers evaluated the emergence and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in Canada.

15 Dec 2022

SARS CoV 2 News and Research

Excess COVID-19-associated death estimates by World Health Organization

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Study reports that delaying surgery post-COVID-19 reduces the risk of postoperative cardiovascular issues

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

The impact of the US vaccination program on reducing infections, hospitalizations, and deaths

Data mining approaches for the detection of signals associated with pediatric post-acute sequelae of COVID-19

mRNA vaccine methodologies: Production, value and spectrometer use

New system based on AI enables mass detection of Covid cases with a sensitivity of 97%

Unexpected findings on the risk of SARS-CoV-2 infection

Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

The UK's growing burden of long-COVID

Novel machine learning method detects animal coronaviruses that might infect humans

New immunosensor could be a fast, inexpensive, and convenient tool to detect COVID-19

Exploring dynamics of emergence and spread of SARS-CoV-2 variants of concern

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News